Genome-wide CRISPR-Cas9 screen to identify genes involved in radiotherapy response
The challenge of radiotherapy resistance in cancer treatment is a significant impediment to effective patient care, particularly as cancer remains a leading cause of death. This project aimed at identifying RT escape mechanisms using functional CRISPR-Cas9 genome-scale knockout genetic screens in vitro.